The long and winding road for the development of tasquinimod as an oral second-generation quinoline-3-carboxamide antiangiogenic drug for the treatment of prostate cancer

Author： Isaacs John T  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.10, 2010-10, pp. : 1235-1243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Long and Winding Road to Cancer Treatment: The Trail System

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-01 ,pp. : 2819-2833

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic Drug Interactions Between Oral Contraceptives and Second-Generation Anticonvulsants

By Wilbur K.  

Clinical Pharmacokinetics, Vol. 38, Iss. 4, 2000-04 ,pp. : 355-365

Adis International

Access to resources Recommend Favorite

Reply to the long and winding road in cancer survivorship care

By Dawes Aaron J.   Maggard-Gibbons Melinda  

Cancer, Vol. 121, Iss. 20, 2015-10 ,pp. : 3750-3750

Blackwell Publishing

Access to resources Recommend Favorite

The long and winding road in cancer survivorship care

By Zanet Ernesto   Michieli Mariagrazia   Tirelli Umberto  

Cancer, Vol. 121, Iss. 20, 2015-10 ,pp. : 3748-3749

Blackwell Publishing

Access to resources Recommend Favorite

Custirsen (OGX-011): a second-generation antisense inhibitor of clusterin for the treatment of cancer

By Chi Kim N   Zoubeidi Amina   Gleave Martin E  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 12, 2008-12 ,pp. : 1955-1962

Informa Healthcare

Access to resources Recommend Favorite